SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Better Choice Inc. (NYSE American – BTTR)
BALA CYNWYD – January 3, 2025/Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Better Choice Company Inc. (“Better Choice” or the “Company”) (NYSE American – BTTR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the merger of the Company with SRx Health Solutions Inc. (“SRx Health”) Under the terms of the agreement, securityholders of SRx Health will own approximately 85% of the combined company and securityholders of Better Choice will own approximately 15% of the combined company, on a fully diluted basis.
The investigation concerns whether the Better Choice Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Company shareholders in the combined company.
If you own shares of Better Choice stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at clients@brodsky-smith.com, or call toll free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.